Filing Details
- Accession Number:
- 0001179110-12-009809
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-08 16:40:12
- Reporting Period:
- 2012-06-07
- Filing Date:
- 2012-06-08
- Accepted Time:
- 2012-06-08 15:40:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884629 | Watson Pharmaceuticals Inc | WPI | Pharmaceutical Preparations (2834) | 953872914 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236490 | Jack Michelson | 335 Basswood Drive Northbrook IL 60062 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0033 | Acquisiton | 2012-06-07 | 10,000 | $36.80 | 26,064 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.0033 | Disposition | 2012-06-07 | 10,000 | $69.79 | 16,064 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.0033 | Disposition | 2012-06-07 | 10,000 | $69.80 | 6,064 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0033 | Non-Qualified Options to Purchase Common Stock | Disposition | 2012-06-07 | 10,000 | $0.00 | 10,000 | $36.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2006-05-19 | 2013-05-19 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.61to $70.36, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.63 to $70.35, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.
Billionaire Hedge Funds
